Wy 41747

Names

[ Name ]:
Wy 41747

[Synonym ]:
(4R,7S,10S,11E,13S,16S,19S,22R,23E,25S,26E,28S,31S,34S,35E,37R)-37-Amino-19-(4-aminobutyl)-13,25,28-tribenzyl-6,9,12,15,18,21,24,27,30,33,36-undecahydroxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-31,34-bis(1H-imidazol-5-ylmethyl)-22-(1H-indol-3-ylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriaconta-5,8,11,14,17,20,23,26,29,32,35-undecaene-4-carboxylic acid
1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriaconta-5,8,11,14,17,20,23,26,29,32,35-undecaene-4-carboxylic acid, 37-amino-19-(4-aminobutyl)-6,9,12,15,18,21,24,27,30,33,36-undecahydroxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-31,34-bis(1H-imidazol-5-ylmethyl)-22-(1H-indol-3-ylmethyl)-13,25,28-tris(phenylmethyl)-, (4R,7S,10S,11E,13S,16S,19S,22R,23E,25S,26E,28S,31S,34S,35E,37R)-
Des-ala1

Biological Activity

[Description]:

Wy 41747 is a long-acting Somatostatin analogue. Wy 41747 can be used for the research of diabetes mellitus[1].

[Related Catalog]:

Signaling Pathways >> Others >> Others

Research Areas >> Metabolic Disease

[In Vitro]

Wy 41747 可以改善 I 型糖尿病患者的糖尿病控制[1]。

[References]

[1]. Dimitriadis G, et, al. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism. 1983 Oct;32(10):987-92.

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
1749.2±75.0 °C at 760 mmHg

[ Molecular Formula ]:
C₇₃H₉₂N₁₈O₁₆S₂

[ Molecular Weight ]:
1541.753

[ Flash Point ]:
1011.7±37.1 °C

[ Exact Mass ]:
1540.638062

[ LogP ]:
-6.23

[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C

[ Index of Refraction ]:
1.710

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.